billHR9103Event Tuesday, June 2, 2026Analyzed

To prohibit Federal research agencies and recipients of Federal research grants from using a prohibited diversity, equity, or inclusion practice with respect to Federal research grants, and for other purposes.

Neutral

Summary

HR9103 is an early-stage bill referred to committee with no funding authorization. It prohibits certain diversity practices in federal research grants but has no direct market impact on any publicly traded company at this stage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR9103 is a procedural early-stage bill with no funding or direct market impact.
  • 2.No publicly traded company is clearly affected; causal chains cannot be established.
  • 3.Investors should ignore this bill until it advances to committee markup or gains significant cosponsorship.

Market Implications

No market implications at this stage. The bill is purely procedural and does not affect any sector or company revenue. Investors should focus on bills with funding authorizations or clear regulatory mechanisms.

Full Analysis

On June 2, 2026, Representative Ralph Norman (R-SC) introduced HR9103, which would prohibit federal research agencies and grant recipients from using prohibited diversity, equity, or inclusion practices. The bill was referred to the House Committee on Science, Space, and Technology, its only committee assignment. With only one cosponsor and no further action, this bill is in the earliest legislative stage.

The bill authorizes no funding—it is a policy restriction, not a spending measure. It does not create contracts, tax credits, or procurement programs. The mechanism is a prohibition on certain practices by grant recipients, but the specific prohibited practices are not defined in the provided data, and the bill has not been marked up or reported by committee.

No publicly traded company is directly named or clearly affected by this bill. Federal research grants are distributed across universities, nonprofits, and some private sector R&D, but the impact on any single company's revenue is speculative and unquantifiable at this stage. The bill's early stage and lack of detail prevent any confident causal chain to a specific ticker.

The legislative path requires committee hearings, markup, floor votes in both chambers, and presidential action. With no companion bill in the Senate and minimal cosponsorship, passage probability is low in the near term. Investors should monitor committee activity but no actionable market signal exists today.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 2, 2026

Promoting Advanced Artificial Intelligence Innovation and Security

This executive order directs multiple federal agencies to prioritize cybersecurity hardening of national security, Department of War, and civilian government systems within 30 days. It establishes a classified benchmarking process for 'covered frontier models' and a voluntary framework for AI developers to provide early access to such models to the government for cybersecurity purposes. It also creates an AI cybersecurity clearinghouse, expands cybersecurity hiring pathways, and directs enforcement against AI-enabled computer crimes.

presidential_memorandumMay 29, 2026

Approving Critical Position Pay Authority for National Security Investment Workforce

This memorandum authorizes the Office of Personnel Management to allocate up to 400 critical positions with pay up to $400,000 to recruit specialized talent for national security investment programs, focusing on critical minerals, advanced materials, and strategic supply chains. It directs OPM and OMB to oversee allocation and ensure pay is used only to recruit or retain exceptionally qualified individuals. The action aims to accelerate domestic mineral production and reduce foreign dependence.

Exec OrderMay 19, 2026

Integrating Financial Technology Innovation into Regulatory Frameworks

This executive order directs federal financial regulators to review and streamline regulations that hinder fintech innovation, particularly for small and emerging firms, and requests the Federal Reserve to evaluate expanding access to its payment accounts and services for non-bank and digital asset firms. It aims to reduce barriers to entry and encourage partnerships between fintech firms and traditional financial institutions, with specific deadlines for reviews and reports.